Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study.

Tereza Deissova, Michaela Cvanova, Zdenek Kala, Zuzana Jiraskova Zakostelska, Jiri Dolina, Lumir Kunovsky, Radek Kroupa, Zdenek Pavlovsky, Bretislav Lipovy, Zdenek Danek, Lydie Izakovicova Holla, Ondrej Urban, Vit Navratil, Robert Lischke, Tomas Harustiak, Tomas Grolich, Vladimir Prochazka, Ondrej Slaby, Petra Borilova Linhartova
Author Information
  1. Tereza Deissova: RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 602 00 Brno, Czech Republic.
  2. Michaela Cvanova: RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 602 00 Brno, Czech Republic.
  3. Zdenek Kala: Department of Surgery, Institution Shared with University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
  4. Zuzana Jiraskova Zakostelska: Institute of Microbiology of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
  5. Jiri Dolina: Department of Gastroenterology and Internal Medicine, Institution Shared with University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
  6. Lumir Kunovsky: Department of Surgery, Institution Shared with University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
  7. Radek Kroupa: Department of Gastroenterology and Internal Medicine, Institution Shared with University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
  8. Zdenek Pavlovsky: Department of Pathology, Institution Shared with University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
  9. Bretislav Lipovy: Department of Burns and Plastic Surgery, Institution Shared with University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
  10. Zdenek Danek: RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 602 00 Brno, Czech Republic.
  11. Lydie Izakovicova Holla: Department of Pathophysiology, Faculty of Medicine, Masaryk University, Kamenice 735/5, 625 00 Brno, Czech Republic.
  12. Ondrej Urban: 2nd Department of Internal Medicine - Gastroenterology and Geriatrics, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University, I. P. Pavlova 6, 779 00 Olomouc, Czech Republic.
  13. Vit Navratil: 2nd Department of Internal Medicine - Gastroenterology and Geriatrics, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University, I. P. Pavlova 6, 779 00 Olomouc, Czech Republic.
  14. Robert Lischke: 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 150 06 Prague, Czech Republic.
  15. Tomas Harustiak: 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 150 06 Prague, Czech Republic.
  16. Tomas Grolich: Department of Surgery, Institution Shared with University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
  17. Vladimir Prochazka: Department of Surgery, Institution Shared with University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
  18. Ondrej Slaby: Central European Institute of Technology, Masaryk University, Kamenice 735/5, 625 00 Brno, Czech Republic.
  19. Petra Borilova Linhartova: RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 602 00 Brno, Czech Republic. ORCID

Abstract

The epidermal growth factor () and its receptor () gene-gene interactions were shown to increase the susceptibility to esophageal cancer. However, the role of the EGF/EGFR pathway in the development of gastroesophageal reflux disease (GERD) and its complications (reflux esophagitis (RE), Barrett's esophagus (BE), and esophageal adenocarcinoma (EAC)) remains unclear. This association study is aimed at investigating functional and gene polymorphisms, their mRNA expression in esophageal tissues, and EGF plasma levels in relation to RE, BE, and EAC development in the Central European population. 301 patients with RE/BE/EAC (cases) as well as 98 patients with nonerosive reflux disease (NERD) and 8 healthy individuals (controls) were genotyped for +61 A>G (rs4444903) and +142285 G>A (rs2227983) polymorphisms using the TaqMan quantitative polymerase chain reaction (qPCR). In random subgroups, the and mRNA expressions were analyzed by reverse transcription qPCR in esophageal tissue with and without endoscopically visible pathological changes; and the EGF plasma levels were determined by enzyme-linked immunosorbent assay. None of the genotyped SNPs nor genotype interactions were associated with RE, BE, or EAC development ( > 0.05). Moreover, mRNA expression of neither nor differed between samples of the esophageal tissue with and without endoscopically visible pathology ( > 0.05) nor between samples from patients with different diagnoses, i.e., RE, BE, or EAC ( > 0.05). Nevertheless, the lower mRNA expression in carriers of combined genotypes AA +61 (rs4444903) and GG +142285 (rs2227983; < 0.05) suggests a possible direct/indirect effect of - gene interactions on gene expression. In conclusion, and gene variants and their mRNA/protein expression were not associated with RE, BE or EAC development in the Central European population.

References

  1. Minerva Gastroenterol Dietol. 2007 Jun;53(2):127-41 [PMID: 17557041]
  2. Clin Cancer Res. 2008 May 15;14(10):3216-22 [PMID: 18483390]
  3. Am J Cancer Res. 2017 May 01;7(5):1016-1036 [PMID: 28560055]
  4. J Surg Res. 2015 Jul;197(1):32-8 [PMID: 25818979]
  5. Neurogastroenterol Motil. 2015 Sep;27(9):1202-13 [PMID: 26053301]
  6. Inflamm Bowel Dis. 1999 Feb;5(1):44-60 [PMID: 10028449]
  7. Mod Pathol. 2004 Oct;17(10):1282-8 [PMID: 15167938]
  8. Dis Esophagus. 2015 Nov-Dec;28(8):750-6 [PMID: 24961755]
  9. Dig Dis Sci. 1998 Sep;43(9 Suppl):14S-22S [PMID: 9753221]
  10. Int J Environ Res Public Health. 2022 Apr 27;19(9): [PMID: 35564692]
  11. PLoS One. 2014 Jun 19;9(6):e100326 [PMID: 24945674]
  12. Gastroenterology. 1996 Jul;111(1):28-36 [PMID: 8698221]
  13. J Hum Genet. 2012 Jan;57(1):26-32 [PMID: 22129558]
  14. J Gastroenterol Hepatol. 1998 Nov;13(S3):S149-S155 [PMID: 28976654]
  15. Am J Physiol Gastrointest Liver Physiol. 2002 May;282(5):G866-76 [PMID: 11960783]
  16. Lancet. 2002 Feb 2;359(9304):397-401 [PMID: 11844511]
  17. Mil Med. 2014 Jul;179(7):799-805 [PMID: 25003868]
  18. J Clin Gastroenterol. 2014 Jan;48(1):6-12 [PMID: 23787250]
  19. Onco Targets Ther. 2013 Dec 13;6:1805-12 [PMID: 24363559]
  20. Sci Rep. 2016 Oct 12;6:35227 [PMID: 27731371]
  21. Regul Pept. 1991 Feb 1;32(2):203-15 [PMID: 2034822]
  22. Front Biosci. 1999 Mar 15;4:D303-9 [PMID: 10077540]
  23. Aliment Pharmacol Ther. 2011 Feb;33(4):442-54 [PMID: 21138458]
  24. Nucleic Acids Res. 1988 Feb 11;16(3):1215 [PMID: 3344216]
  25. Ann Oncol. 1997 Dec;8(12):1197-206 [PMID: 9496384]
  26. Ann Surg. 2010 May;251(5):857-64 [PMID: 20101173]
  27. World J Clin Cases. 2018 Aug 16;6(8):176-182 [PMID: 30148145]
  28. Clin Cancer Res. 2006 Dec 15;12(24):7252-60 [PMID: 17189396]
  29. Curr Med Res Opin. 1998;14(3):145-53 [PMID: 9787980]
  30. Carcinogenesis. 2009 Aug;30(8):1363-7 [PMID: 19520791]
  31. Dig Dis Sci. 1996 Aug;41(8):1595-9 [PMID: 8769285]
  32. J Clin Gastroenterol. 1998;27 Suppl 1:S12-20 [PMID: 9872493]
  33. Eur J Gastroenterol Hepatol. 1995 Oct;7(10):933-7 [PMID: 8590137]
  34. Mediators Inflamm. 2016;2016:1927348 [PMID: 27524860]
  35. Inflammopharmacology. 2005;13(1-3):1-13 [PMID: 16259724]
  36. Arch Surg. 2006 May;141(5):476-81; discussion 481-2 [PMID: 16702519]
  37. J Neurogastroenterol Motil. 2016 Oct 30;22(4):575-588 [PMID: 27703114]
  38. Endoscopy. 2017 Feb;49(2):191-198 [PMID: 28122386]
  39. Gastroenterology. 1992 Feb;102(2):695-8 [PMID: 1732139]
  40. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10217-21 [PMID: 7937865]
  41. Pathol Res Pract. 2019 May;215(5):885-892 [PMID: 30723053]
  42. Am J Physiol. 1990 Sep;259(3 Pt 2):R545-8 [PMID: 2396713]
  43. Kidney Int. 2002 May;61(5):1627-34 [PMID: 11967012]
  44. ScientificWorldJournal. 2020 May 31;2020:3506207 [PMID: 32549798]
  45. Clin Transl Sci. 2009 Aug;2(4):286-93 [PMID: 20443907]
  46. Oncol Res. 2008;17(4):167-74 [PMID: 18773861]
  47. PLoS One. 2019 Jan 24;14(1):e0211212 [PMID: 30677083]
  48. Cancer Res. 2006 Dec 15;66(24):11605-12 [PMID: 17178854]
  49. Oxid Med Cell Longev. 2021 Nov 27;2021:9306760 [PMID: 34873433]
  50. J Physiol Pharmacol. 2003 Dec;54 Suppl 4:143-54 [PMID: 15075456]

MeSH Term

Adenocarcinoma
Barrett Esophagus
Carrier Proteins
Case-Control Studies
Epidermal Growth Factor
ErbB Receptors
Esophageal Neoplasms
Esophagitis, Peptic
Gastroesophageal Reflux
Humans
Polymorphism, Single Nucleotide
RNA, Messenger

Chemicals

Carrier Proteins
RNA, Messenger
Epidermal Growth Factor
ErbB Receptors

Word Cloud

Created with Highcharts 10.0.0esophagealREBEEACexpressiondevelopmentgenemRNA005interactionsrefluxpatients>diseaseBarrett'spolymorphismsEGFplasmalevelsCentralEuropeanpopulationgenotyped+61rs4444903+142285rs2227983qPCRtissuewithoutendoscopicallyvisibleassociatedsamplesepidermalgrowthfactorreceptorgene-geneshownincreasesusceptibilitycancerHoweverroleEGF/EGFRpathwaygastroesophagealGERDcomplicationsesophagitisesophagusadenocarcinomaremainsunclearassociationstudyaimedinvestigatingfunctionaltissuesrelation301RE/BE/EACcaseswell98nonerosiveNERD8healthyindividualscontrolsA>GG>AusingTaqManquantitativepolymerasechainreactionrandomsubgroupsexpressionsanalyzedreversetranscriptionpathologicalchangesdeterminedenzyme-linkedimmunosorbentassayNoneSNPsgenotypeMoreoverneitherdifferedpathologydifferentdiagnosesieNeverthelesslowercarrierscombinedgenotypesAAGG<suggestspossibledirect/indirecteffect-conclusionvariantsmRNA/proteinLackAssociationEpidermalGrowthFactorReceptorRefluxEsophagitisEsophagusEsophagealAdenocarcinoma:Case-ControlStudy

Similar Articles

Cited By (1)